Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Erika, Kettner"'
Autor:
Ricarda Seidensticker, Max Seidensticker, Kathleen Doegen, Konrad Mohnike, Kerstin Schütte, Patrick Stübs, Erika Kettner, Maciej Pech, Holger Amthauer, Jens Ricke
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Aim. To assess the outcomes of patients with unresectable intrahepatic cholangiocellular carcinoma (ICC) treated by a tailored therapeutic approach, combining systemic with advanced image-guided local or locoregional therapies. Materials and Methods.
Externí odkaz:
https://doaj.org/article/d13cd24833144d8a8c9fa0d1a477208d
Autor:
Sabine Neser, Antje Haas, Ralph Naumann, Erika Kettner, Robert Rohrberg, Kathrin Haifa Al-Ali, Ursula Haak, Michael Herold, Christian Klinkenstein, Astrid Franke, Mathias Freund, Gottfried Dölken, Ulrich Mey, Ullrich von Grünhagen, Michael Aβmann, Klaus Höffken, Stefanie Srock, Wolfgang Knauf, Thomas Ittel, Andreas Neubauer
Publikováno v:
Journal of Clinical Oncology. 25:1986-1992
Purpose Rituximab has been shown to be active in follicular lymphoma (FL), both as monotherapy and in combination with chemotherapy. We conducted a randomized trial comparing mitoxantrone, chlorambucil, and prednisolone (MCP) chemotherapy plus rituxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5a75ad1f7f18a4a63fcdb50a725f2a
https://doi.org/10.1200/jco.2006.06.4618
https://doi.org/10.1200/jco.2006.06.4618
Autor:
A. Franke, Andreas Schwarzer, M. Herold, F. Fiedler, U von Grünhagen, J Doepper, G Dölken, Thoralf Lange, W Schultze, Cornelia Winkelmann, Hoffmann Fa, Erika Kettner, Elvira Edel, R. Uhle, Dietger Niederwieser, Sabine Leiblein, E Schwalbe, R. Krahl, Wolfram Pönisch, Rita Subert, Klaus Dachselt, Rita Pasold, Michael W. Deininger, W. Helbig, J. Steglich, M. Freund, P. Richter
Publikováno v:
Bone Marrow Transplantation. 27:1125-1132
Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high proportion of Ph-negative progenitor cells in the graft is desirable. We report here the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b63c7b19d06e00af6d4092a7be4ff4
https://doi.org/10.1038/sj.bmt.1703057
https://doi.org/10.1038/sj.bmt.1703057
Autor:
John S. Macdonald, Erika Kettner, Howard S. Hochster, William J. John, Klaus Becker, Hans-Joachim Schmoll, Ramesh K. Ramanathan, Shengyan Hong, H. Kröning, Florian Lordick
Publikováno v:
Clinical colorectal cancer. 5(4)
Background Pemetrexed and irinotecan have demonstrated antitumor activity as single agents in lung, pancreatic, breast, and colorectal cancer (CRC). The distinct mechanisms of action and patterns of resistance displayed by pemetrexed and irinotecan m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d9f5e7234f3802f02afa6e9c75fdc2
https://pubmed.ncbi.nlm.nih.gov/16356302
https://pubmed.ncbi.nlm.nih.gov/16356302
Autor:
Andreas du Bois, Andreas Schneeweiss, Wolfgang Eiermann, Hans-Joachim Lück, J. Torode, Ulrich R. Kleeberg, Peter A. Fasching, Jörn Hilfrich, Gunter von Minckwitz, Erika Kettner, Walter Jonat
Publikováno v:
Breast cancer research and treatment. 89(2)
Background. Epidermal growth factor receptor (EGFR) is considered to be a viable drug target in a variety of solid tumors. The clinical benefit and safety of the EGFR tyrosine kinase inhibitor gefitinib (‘Iressa’)1 was evaluated in this Phase II,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7aa70b68ab2f2cce3df5b375915e114
https://pubmed.ncbi.nlm.nih.gov/15692759
https://pubmed.ncbi.nlm.nih.gov/15692759
Autor:
Marko, Kornmann, Wolfgang, Schwabe, Silvia, Sander, Martina, Kron, Jörn, Sträter, Sucan, Polat, Erika, Kettner, Hans F, Weiser, Wolfram, Baumann, Harald, Schramm, Peter, Häusler, Kati, Ott, Detlev, Behnke, Ludger, Staib, Hans G, Beger, Karl H, Link
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(11)
Despite adjuvant 5-fluorouracil (5-FU) therapy, approximately 30% of patients with International Union against Cancer stage II and III colorectal cancer develop recurrence. In this study, we determined the prognostic value of thymidylate synthase (TS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e70c502a5ddb4434ba9f386f8194686e
https://pubmed.ncbi.nlm.nih.gov/14519634
https://pubmed.ncbi.nlm.nih.gov/14519634
Autor:
Norma Peter, Antje Schulze, Christoph Kahl, Detlev Hähling, Hans-Heinrich Wolf, Thomas Heinicke, Herbert G. Sayer, Ute Kreibich, Andreas Hochhaus, Georg Maschmeyer, Mathias Hänel, Erika Kettner, Haifa Kathrin Al-Ali, Rainer Krahl, Sebastian Scholl, Michael Herold, Dietrich Kämpfe, Thomas Fischer, Christian Junghanss, Lutz Uharek, Dietger Niederwieser
Publikováno v:
Blood. 124:3664-3664
The incidence of acute myeloid leukemia (AML) is age-dependent with the majority of patients (pts) being older than 60 years at diagnosis. Treatment of these pts needs to be well balanced between sufficient efficacy and tolerable toxicity. Here, we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2469b8b7e4eb7055aa6b47c930a933cc
https://doi.org/10.1182/blood.v124.21.3664.3664
https://doi.org/10.1182/blood.v124.21.3664.3664
Autor:
G Schönfeld, H Kröning, Hans Kreipe, Wolfram Kleeberger, H. K. Al-Ali, Dietger Niederwieser, E König, Erika Kettner, Martin Bredt
Publikováno v:
Bone Marrow Transplantation. 31:1071-1072
Late-onset Epstein–Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::196c547d7861ce9360fe8807502158c6
https://doi.org/10.1038/sj.bmt.1704035
https://doi.org/10.1038/sj.bmt.1704035
Autor:
Cornelia Becker, Ute Kreibich, Christian Junghanß, Rainer Krahl, Erika Kettner, Mathias Haenel, Hans-Heinrich Wolf, Thomas Ittel, Antje Schulze, Dietrich Kaempfe, Renate Huhn, Georg Maschmeyer, W. Helbig, Axel Florschuetz, Bernd Opitz, Dietger Niederwieser, Michael Assmann, Ulrich Wedding, Dirk Hasenclever, Ernst Zschuppe, Veronika Schirmer, Astrid Franke, Wolfram Poenisch, Mathias Schulze, Norbert Grobe, Norma Peter, Johannes G. Meran, Detlev Haehling, Gottfried Doelken
Publikováno v:
Blood. 112:2966-2966
Clinical trials on different cytarabine doses for treatment of AML provide evidence of a dose response effect, but also for increase toxicity after high dose AraC (HDAC). Pharmacokinetic measurements of cytarabine-triphosphate (AraC-CTP), which is th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aec8f63358c6111324f6cf29e15e77f9
https://doi.org/10.1182/blood.v112.11.2966.2966
https://doi.org/10.1182/blood.v112.11.2966.2966
Autor:
Erika Kettner, Norma Peter, Cornelia Becker, W. Helbig, Axel Florschuetz, Ute Kreibich, A. Franke, Michael Cross, H.K. Al Ali, Manfred Schulze, Heiner Wolf, U. Mahlknecht, Dietger Niederwieser, A. Gerhardt, L Uharek, Detlev Haehling, U. Wedding, G. Doelken, Wolfram Poenisch, Antje Schulze, Simone Heyn, Bernhard Opitz, R. Krahl, N. Zojer, Ernst Zschuppe, M. Freund
Publikováno v:
Blood. 110:1854-1854
The incidence of AML increases with age. More than half of the patients (pts) are over 60 years (y) at time of diagnosis. On the other hand, elderly pts are clearly under-represented in the literature. The AML 97 study was designed to register all pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e09472eec43f5e4f30511b134212ac7c
https://doi.org/10.1182/blood.v110.11.1854.1854
https://doi.org/10.1182/blood.v110.11.1854.1854